Updated Austrian treatment algorithm in HER2+ metastatic breast cancer.

Rupert Bartsch; Simon Peter Gampenrieder; Gabriel Rinnerthaler; Edgar Petru; Daniel Egle; Andreas Petzer; Marija Balic; Ursula Pluschnig; Thamer Sliwa; Christian Singer

doi:10.1007/s00508-021-01987-9

Updated Austrian treatment algorithm in HER2+ metastatic breast cancer.

Rupert Bartsch, Simon Peter Gampenrieder (Co-author), Gabriel Rinnerthaler (Co-author), Edgar Petru, Daniel Egle, Andreas Petzer, Marija Balic, Ursula Pluschnig, Thamer Sliwa, Christian Singer

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Review article › peer-review

2 Citations (Web of Science)

Original language	English
Pages (from-to)	63-72
Journal	WIENER KLINISCHE WOCHENSCHRIFT
Volume	134
Issue number	1-2
DOIs	https://doi.org/10.1007/s00508-021-01987-9
Publication status	Published - 2022

Keywords

OPEN-LABEL
TRASTUZUMAB EMTANSINE
PLUS TRASTUZUMAB
CHEMOTHERAPY
PERTUZUMAB
SURVIVAL
PROGRESSION
LAPATINIB
CAPECITABINE
COMBINATION

Access to Document

10.1007/s00508-021-01987-9

Cite this

@article{67e993d71c484852902d4279b8f28ddb,

title = "Updated Austrian treatment algorithm in HER2+ metastatic breast cancer.",

keywords = "OPEN-LABEL, TRASTUZUMAB EMTANSINE, PLUS TRASTUZUMAB, CHEMOTHERAPY, PERTUZUMAB, SURVIVAL, PROGRESSION, LAPATINIB, CAPECITABINE, COMBINATION",

author = "Rupert Bartsch and Gampenrieder, {Simon Peter} and Gabriel Rinnerthaler and Edgar Petru and Daniel Egle and Andreas Petzer and Marija Balic and Ursula Pluschnig and Thamer Sliwa and Christian Singer",

note = "Gampenrieder, Rinnerthaler: Third Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University Salzburg, M{\"u}llner Hauptstra{\ss}e 48, 5020, Salzburg, Austria.",

year = "2022",

doi = "10.1007/s00508-021-01987-9",

language = "English",

volume = "134",

pages = "63--72",

journal = "WIENER KLINISCHE WOCHENSCHRIFT",

issn = "0043-5325",

publisher = "Springer Nature",

number = "1-2",

}

TY - JOUR

T1 - Updated Austrian treatment algorithm in HER2+ metastatic breast cancer.

AU - Bartsch, Rupert

AU - Gampenrieder, Simon Peter

AU - Rinnerthaler, Gabriel

AU - Petru, Edgar

AU - Egle, Daniel

AU - Petzer, Andreas

AU - Balic, Marija

AU - Pluschnig, Ursula

AU - Sliwa, Thamer

AU - Singer, Christian

N1 - Gampenrieder, Rinnerthaler: Third Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020, Salzburg, Austria.

PY - 2022

Y1 - 2022

KW - OPEN-LABEL

KW - TRASTUZUMAB EMTANSINE

KW - PLUS TRASTUZUMAB

KW - CHEMOTHERAPY

KW - PERTUZUMAB

KW - SURVIVAL

KW - PROGRESSION

KW - LAPATINIB

KW - CAPECITABINE

KW - COMBINATION

U2 - 10.1007/s00508-021-01987-9

DO - 10.1007/s00508-021-01987-9

M3 - Review article

C2 - 35089396

SN - 0043-5325

VL - 134

SP - 63

EP - 72

JO - WIENER KLINISCHE WOCHENSCHRIFT

JF - WIENER KLINISCHE WOCHENSCHRIFT

IS - 1-2

ER -